Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong.

Tsoi KKF, Ho JMW, Chan FCH, Sung JJY.

Int J Cancer. 2018 Dec 21. doi: 10.1002/ijc.32083. [Epub ahead of print]

PMID:
30575949
2.

Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Whitlock EP, Williams SB, Burda BU, Feightner A, Beil T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

3.

Pediatric stroke among Hong Kong Chinese subjects.

Chung B, Wong V.

Pediatrics. 2004 Aug;114(2):e206-12.

PMID:
15286258
4.

Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.

Tsoi KK, Chan FC, Hirai HW, Sung JJ.

J Gastroenterol Hepatol. 2018 Oct;33(10):1728-1736. doi: 10.1111/jgh.14261. Epub 2018 May 16.

PMID:
29665624
5.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

6.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

7.

Aspirin and cancer risk: an updated quantitative review to 2005.

Bosetti C, Gallus S, La Vecchia C.

Cancer Causes Control. 2006 Sep;17(7):871-88. Review.

PMID:
16841255
8.

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.

Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE.

J Natl Cancer Inst. 2007 Apr 18;99(8):608-15.

PMID:
17440162
9.

Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.

Cao Y, Nishihara R, Wu K, Wang M, Ogino S, Willett WC, Spiegelman D, Fuchs CS, Giovannucci EL, Chan AT.

JAMA Oncol. 2016 Jun 1;2(6):762-9. doi: 10.1001/jamaoncol.2015.6396.

10.

The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.

Huang WK, Chiou MJ, Yu KH, Lin YC, Yang TS, Chen JS, Kuo CF, See LC.

Aliment Pharmacol Ther. 2013 Aug;38(4):432-9. doi: 10.1111/apt.12388. Epub 2013 Jun 25.

11.

Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network.

Cea Soriano L, Soriano-Gabarró M, García Rodríguez LA.

Int J Cardiol. 2017 Dec 1;248:376-381. doi: 10.1016/j.ijcard.2017.06.052.

PMID:
28942878
12.

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):47-55.

PMID:
15998890
13.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

PMID:
15928301
14.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

15.

New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.

García Rodríguez LA, Soriano-Gabarró M, Bromley S, Lanas A, Cea Soriano L.

BMC Cancer. 2017 Sep 7;17(1):637. doi: 10.1186/s12885-017-3594-9.

16.

Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Chubak J, Kamineni A, Buist DSM, Anderson ML, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep.

17.

Low-dose aspirin use and cancer characteristics: a population-based cohort study.

Jonsson F, Yin L, Lundholm C, Smedby KE, Czene K, Pawitan Y.

Br J Cancer. 2013 Oct 1;109(7):1921-5. doi: 10.1038/bjc.2013.411. Epub 2013 Jul 25.

18.

Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.

Hollestein LM, van Herk-Sukel MP, Ruiter R, de Vries E, Mathijssen RH, Wiemer EA, Stijnen T, Coebergh JW, Lemmens VE, Herings RM, Stricker BH, Nijsten T.

Int J Cancer. 2014 Jul 1;135(1):157-65. doi: 10.1002/ijc.28634. Epub 2013 Dec 9.

19.

A long-term risk-benefit analysis of low-dose aspirin in primary prevention.

Wu IC, Hsieh HM, Yu FJ, Wu MC, Wu TS, Wu MT.

Eur J Clin Invest. 2016 Feb;46(2):130-40. doi: 10.1111/eci.12575. Epub 2016 Jan 4.

PMID:
26640116
20.

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):56-65.

PMID:
15998891

Supplemental Content

Support Center